Yu Yi, Zheng Bojun, Xu Jian, Li Jian
Department of Critical Care Medicine The Second Affiliated Hospital of Guangzhou University of Chinese Medicine Guangzhou China.
Health Sci Rep. 2025 Jul 21;8(7):e70994. doi: 10.1002/hsr2.70994. eCollection 2025 Jul.
There is limited research on the clinical efficacy of electroacupuncture (EA) for sepsis-induced acute gastrointestinal injury (S-AGI). This study aimed to examine the effects of EA at "Zusanli" (ST36) and "Guanyuan" (RN4) on S-AGI.
We identified 255 patients with S-AGI from March 2018 to September 2021 who underwent treatment at the Department of Critical Care Medicine, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine. Among these patients, 50 received EA, and 203 did not. After performing 1:2 propensity score matching by sex, age, baseline comorbidity, infection source, laboratory results, and AGI classification, there were 100 patients in the non-EA cohort. In addition to conventional therapies, patients in the treatment group underwent 30 min of EA at ST36-RN4 twice a day for 7 days. The 28-day mortality was recorded.
Our study included 150 participants diagnosed with S-AGI, with an average age of 70.3 years. Kaplan-Meier survival analysis indicated an association between EA treatment and significantly lower 28-day mortality. Adjusted multivariable Cox models consistently suggested a significant reduction in the prevalence of mortality that was associated with the use of EA. After accounting for confounding factors, there was an observed 54% decrease in 28-day mortality among patients who received EA (hazard ratio [HR]: 0.46, 95% confidence interval [CI]: 0.22-0.95, < 0.05). Subgroup analyses further supported these associations.
There is an indication that EA at ST36-RN4 may be associated with protective effects for patients with S-AGI.
关于电针(EA)治疗脓毒症诱导的急性胃肠损伤(S-AGI)的临床疗效研究有限。本研究旨在探讨针刺“足三里”(ST36)和“关元”(RN4)对S-AGI的影响。
我们纳入了2018年3月至2021年9月在广州中医药大学第二附属医院重症医学科接受治疗的255例S-AGI患者。其中,50例接受电针治疗,203例未接受。在按性别、年龄、基线合并症、感染源、实验室检查结果和AGI分级进行1:2倾向评分匹配后,非电针组有100例患者。除常规治疗外,治疗组患者每天两次在ST36-RN4行电针治疗30分钟,共7天。记录28天死亡率。
我们的研究纳入了150例诊断为S-AGI的参与者,平均年龄为70.3岁。Kaplan-Meier生存分析表明电针治疗与显著降低的28天死亡率相关。校正后的多变量Cox模型一致表明,与使用电针相关的死亡率患病率显著降低。在考虑混杂因素后,接受电针治疗的患者28天死亡率下降了54%(风险比[HR]:0.46,95%置信区间[CI]:0.22-0.95,P<0.05)。亚组分析进一步支持了这些关联。
有迹象表明,ST36-RN4电针可能对S-AGI患者具有保护作用。